Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways

Journal of the Royal Society Interface

Volumn 3, Issue 9, 2006, Pages 515-526

  Hua, Fei ^a   Hautaniemi, Sampsa ^a   Yokoo, Rayka ^a   Lauffenburger, Douglas A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Apoptosis; Machine learning; Mechanistic modelling; Signalling pathways; Systems biology

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; CLUSTER ANALYSIS; DATA ANALYSIS; HUMAN; HUMAN CELL; INFORMATION PROCESSING; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR MECHANICS; MULTIVARIATE ANALYSIS; PROTEIN CONTENT; SIGNAL TRANSDUCTION; SIMULATION; STATISTICAL MODEL;

EID: 33747603487     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2005.0109     Document Type: Article

References (32)

1. Adam, B. L. et al. 2002 Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62, 3609-3614.
2. Basso, K., Margolin, A. A., Stolovitzky, G., Klein, U., Dalla-Favera, R. & Califano, A. 2005 Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390. (doi:10.1038/ng1532)
3. Bentele, M., Lavrik, L. Ulrich, M., Stosser, S.. Heermann, D. W., Kalthoff, H., Krammer, P. H. & Eils, R. 2004 Mathematical modelling reveals threshold mechanism in CD95-induced apoptosis. J. Cell. Biol. 166, 839-851. (doi:10.1083/jcb.200404158)
4. Bratton, S. B., Lewis, J., Butterworth, M., Duckett, C. S. & Cohen, G. M. 2002 XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ. 9, 881-892. (doi:10.1038/sj.cdd.4401069)
5. Breiman, L. 2001a Random forests. Mach. Learn. 45, 5-32. (doi:10.1023/A:1010933404324)
6. Breiman, L. 2001b Statistical modelling: the two cultures. Stat. Sci. 16, 199-231. (doi:10.1214/ss/1009213726)
7. Breiman, L., Friedman, J. H., Olshen, R. A. & Stone, C. J. 1984 Classification and regression trees. London: Chapman & Hall.
8. de Pillis, L. G., Radunskaya, A. E. & Wiseman, C. L. 2005 A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res. 65, 7950-7958.
9. Duda, R. O., Hart, P. E. & Stork, D. G. 2001 Pattern recognition. London: Wiley.
10. Frantz, S. 2005 Drug discovery: playing dirty. Nature 437, 942-943. (doi:10.1038/437942a)
11. Fussenegger, M., Bailey, J. E. & Varner, J. 2000 A mathematical model of caspase function in apoptosis. Nat. Biotechnol. 18, 768-774. (doi:10.1038/81208)
12. Gunther, E. C., Stone, D. J., Gerwien, R. W., Bento, P. & Heyes, M. P. 2003 Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc. Natl Acad. Sci. USA 100, 9608-9613. (doi:10.1073/pnas.1632587100)
13. Hautaniemi, S., Kharait, S., Iwabu, A., Wells, A. & Lauffenburger, D. A. 2005 Modelling of signal-response cascades using decision tree analysis. Bioinformatics 21, 2027-2035. (doi:10.1093/bioinformatics/bti278)
14. Hoffmann, A., Levchenko, A., Scott, M. L. & Baltimore, D. 2002 The IkappaB-NF-kappaB signalling module: temporal control and selective gene activation. Science 298, 1241-1245. (doi:10.1126/science.1071914)
15. Hua, F., Cornejo, M. G., Cardone, M. H., Stokes, C. L. & Lauffenburger, D. A. 2005 Effects of Bcl-2 levels on Fas signalling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175, 985-995.
16. Igney, F. H. & Krammer, P. H. 2002 Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288. (doi:10.1038/nrc776)
17. Irmler, M. et al. 1997 Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195. (doi:10.1038/40657)
18. Kholodenko, B. N., Demin, O. V., Moehren, G. & Hoek, J. B. 1999 Quantification of short term signalling by the epidermal growth factor receptor. J. Biol. Chem,. 274, 30 169-30 181. (doi:10.1074/jbc.274.42.30169)
19. Kislinger, T., Gramolini, A. O., Pan, Y., Rahman, K., MacLennan, D. H. & Emili, A. 2005 Proteome dynamics during C2C12 myoblast differentiation. Mol. Cell Proteomics 4, 887-901. (doi:10.1074/mcp.M400182-MCP200)
20. Krammer, P. H. 2000 CD95's deadly mission in the immune system. Nature 407, 789-795. (doi:10.1038/35037728)
21. Landowski, T. H., Qu, N., Buyuksal, L, Painter, J. S. & Dalton, W. S. 1997 Mutations in the Fas antigen in patients with multiple myeloma. Blood 90, 4266-4270.
22. Lavrik, I., Golks, A. & Krammer, P. H. 2005 Death receptor signalling. J. Cell Sci. 2, 265-267. (doi:10.1242/jcs.01610)
23. Ma'ayan, A., Blitzer, R. D. & Iyengar, R. 2005 Toward predictive models of mammalian cells. Annu. Rev. Biophys. Biomol. Struct. 34, 319-349. (doi:10.1146/ annurev.biophys.34.040204.144415)
24. Mencher, S. K. & Wang, L. G. 2005 Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin. Pharmacol. 5, 3. (doi:10.1186/1472-6904-5-3)
25. Nagata, S. 1999 Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55. (doi:10.1146/annurev.genet.33.1.29)
26. Podgorelec, V., Kokol, P., Stiglic, B. & Rozman, I. 2002 Decision trees: an overview and their use in medicine. J. Med. Syst. 26, 445-463. (doi:10.1023/A:1016409317640)
27. Rosenwald, A. et al. 1947 The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937 1937. (doi:10.1056/NEJMoa012914)
28. Roth, B. L., Sheffler, D. J. & Kroezc, W. K. 2004 Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3, 353-359. (doi:10.1038/nrd1346)
29. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H. & Peter, M. E. 1998 Two CD95 (APO-1/Fas) signalling pathways. EMBO J. 17, 1675-1687. (doi:10.1093/emboj/17.6. 1675)
30. Schoeberl, B., Eichler-Jonsson, C., Gilles, E. D. & Muller, G. 2002 Computational modelling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol. 20, 370-375. (doi:10.1038/nbt0402-370)
31. Segal, E., Shapira, M., Regev, A., Pe'er, D., Botstein, D., Koller, D. & Friedman, N. 2003 Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166-176.
32. Wiley, H. S., Shvartsman, S. Y. & Lauffenburger, D. A. 2003 Computational modelling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol. 13, 43-50. (doi:10.1016/S0962-8924(02)00009-0)